Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.
D000241:Adenosine / Q000097:blood; D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D003839:Deoxyadenosines / Q000097:blood; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D015649:Pentostatin; D012263:Ribonucleosides / Q000494:pharmacology*; D014740:Vidarabine / Q000008:administration & dosage / Q000378:metabolism*
D000970:Antineoplastic Agents; D003839:Deoxyadenosines; D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin; D014740:Vidarabine; D000241:Adenosine